Market research
002901.SHE Double Medical Technology Inc
SHE CNY Healthcare
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 16B
- P/E ratio
- 22.55
- Analyst target
- 52
- Dividend yield
- 1.5%
- Beta
- 0.1
Profile
Instrument facts
- Exchange
- SHE
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- CNE1000032W7
- Market cap
- 16B
- P/E ratio
- 22.55
- Analyst target
- 52
- Dividend yield
- 1.5%
- Beta
- 0.1
About
About Double Medical Technology Inc
Double Medical Technology Inc. engages in the research, development, production, and sale of high-value medical consumables in China. The company offers orthopedic trauma implants, spinal implants, joint implants, sports medicine and neurosurgery implants, minimally invasive surgical implants, and dental implants. It also exports its products. The company was formerly known as Xiamen Da Bo Ying Jing Medical Equipment Company Limited. Double Medical Technology Inc. was incorporated in 2004 and is headquartered in Xiamen, China.
Research context
Double Medical Technology Inc appears in PyInvesting’s Shenzhen Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Medical Devices
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the 002901.SHE discussion.
5 years, 7 months ago
Double Medical Technology Inc is currently in a long term downtrend where the price is trading 5.4% below its 200 day moving average.
From a valuation standpoint, the stock is 45.4% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 14.0.
Double Medical Technology Inc's total revenue rose by 33.8% to $437M since the same quarter in the previous year.
Its net income has increased by 20.9% to $163M since the same quarter in the previous year.
Finally, its free cash flow grew by 32.0% to $83M since the same quarter in the previous year.
Based on the above factors, Double Medical Technology Inc gets an overall score of 3/5.